GSGPX
Price
$10.40
Change
+$0.03 (+0.29%)
Updated
Aug 6 closing price
Net Assets
4.96B
RYMQX
Price
$24.55
Change
+$0.03 (+0.12%)
Updated
Aug 6 closing price
Net Assets
14.02M
Interact to see
Advertisement

GSGPX vs RYMQX

Header iconGSGPX vs RYMQX Comparison
Open Charts GSGPX vs RYMQXBanner chart's image
Goldman Sachs Absolute Ret Trckr P
Price$10.40
Change+$0.03 (+0.29%)
VolumeN/A
Net Assets4.96B
Guggenheim Multi-Hedge Strategies A
Price$24.55
Change+$0.03 (+0.12%)
VolumeN/A
Net Assets14.02M
GSGPX vs RYMQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSGPX vs. RYMQX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGPX is a Hold and RYMQX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSGPX has more cash in the bank: 4.96B vs. RYMQX (14M). RYMQX pays higher dividends than GSGPX: RYMQX (2.92) vs GSGPX (1.10). GSGPX was incepted earlier than RYMQX: GSGPX (7 years) vs RYMQX (20 years). RYMQX (2.12) is less costly to investors than GSGPX (0.82). GSGPX is a more actively managed with annual turnover of: 179.00 vs. RYMQX (164.00). GSGPX has a lower initial minimum investment than RYMQX: GSGPX (0) vs RYMQX (2500). GSGPX annual gain was more profitable for investors over the last year : 9.25 vs. RYMQX (-2.50). GSGPX return over 5 years is better than : 18.50 vs. RYMQX (3.46).
GSGPXRYMQXGSGPX / RYMQX
Total Expense Ratio0.732.0635%
Annual Report Gross Expense Ratio0.822.1239%
Fund Existence7 years20 years-
Gain YTD4.012-1.049-382%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets4.96B14M35,436%
Annual Yield % from dividends1.102.9238%
Returns for 1 year9.25-2.50-371%
Returns for 3 years20.63-2.21-933%
Returns for 5 years18.503.46535%
Returns for 10 yearsN/A13.25-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSTV0.760.10
+15.47%
Plus Therapeutics
SERA2.750.30
+12.24%
Sera Prognostics
FCF16.54-0.16
-0.96%
First Commonwealth Financial Corp
KRMN48.60-1.79
-3.55%
Karman Holdings Inc
NVO45.38-1.84
-3.90%
Novo-Nordisk A/S